ArticleBMC public health2026
Regional heterogeneity and the role of social vulnerability in air pollution-related mortality from chronic lower respiratory diseases: a nationwide analysis of the United States (2010-2020).
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Trends in respiratory disease mortality in the United States, 1999-2024.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundFine particulate matter (PM2.5) is a recognized risk factor for chronic lower respiratory diseases (CLRD) mortality. While Environmental Justice frameworks posit that socioeconomically disadvantaged populations bear disproportionate health burdens, nationwide studies using pooled estimates may mask critical geographic and seasonal heterogeneities. This study aimed to evaluate these spatiotemporal variations across the contiguous US and examine effect modification by the Social Vulnerability Index (SVI).
methodsWe analyzed monthly time-series data from 3,108 counties (2010–2020). CLRD mortality data (ICD-10: J40-J47) were obtained from CDC WONDER, and monthly average concentrations of PM2.5 and ozone were aggregated from daily measurements derived from the US EPA Air Quality System using inverse distance weighting (IDW). Generalized Linear Models (GLM) with a negative binomial distribution were employed, adjusting for ozone, temperature, seasonality, and long-term trends. Analyses were stratified by Census Region and season. We introduced an interaction term (PM2.5×SVI) to test for effect modification and used restricted cubic splines (RCS) to visualize exposure-response associations. Sensitivity analyses, including removing ozone adjustment, altering temperature controls, and excluding 2020 data to rule out COVID-19 anomalies, were conducted to verify robustness.
resultsNationwide, the association was borderline (RR = 1.02, 95% CI: 1.00-1.04, P = 0.075), but regional disparities were striking. The Midwest exhibited exceptionally high risk (RR = 2.61, 95% CI: 2.45–2.79, P < 0.001) with a steep exposure-response curve consistent across seasons. Conversely, the South showed a negative association (RR = 0.70, 95% CI: 0.53–0.92, P = 0.043), primarily driven by the warm season. No significant associations were observed in the Northeast or West. Importantly, SVI did not significantly modify the PM2.5-mortality association in any region (P-interaction > 0.05), and results remained robust across sensitivity models.
conclusionsThe impact of PM2.5 on CLRD mortality exhibits substantial regional heterogeneity. The Midwest identified as a highly susceptible hotspot, while the South’s negative association likely reflects exposure misclassification (e.g., air conditioning use). Our findings support the “Universal Susceptibility” hypothesis in the Midwest, suggesting that regional pollution haze poses a consistent threat across socioeconomic spectrums, unaffected by community vulnerability levels. Policy interventions should prioritize region-specific emission controls, particularly in the Midwest.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.